GALVANIZE THERAPEUTICS
Galvanize Therapeutics provides therapeutic products and services and currently operates on stealth mode. The company was founded in 2015 and is headquartered in Menlo Park, California, United States.
GALVANIZE THERAPEUTICS
Industry:
Health Care Medical Device Therapeutics
Founded:
2015-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.galvanizetherapeutics.com
Status:
Active
Contact:
650-257-7535
Total Funding:
48.51 M USD
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Click Therapeutics
Click Therapeutics delivers safe and effective digital treatments to patients in need.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Official Site Inspections
http://www.galvanizetherapeutics.com Semrush global rank: 4.8 M Semrush visits lastest month: 1.91 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Galvanize Therapeutics"
Galvanize
Nov 6, 2023 Steve is vice president of Global Market Development for the airway/COPD division of Galvanize Therapeutics. In this role, he leads commercial development activities for RheOx …See details»
Galvanize - LinkedIn
Galvanize Therapeutics is developing therapies to deliver life-changing healthcare solutions to patients and their doctors at the convergence of biology, engineering, and care delivery.See details»
Galvanize Therapeutics Inc Company Profile | San Carlos, CA ...
Find company research, competitor information, contact details & financial data for Galvanize Therapeutics Inc of San Carlos, CA. Get the latest business insights from Dun & Bradstreet.See details»
Galvanize Therapeutics - PitchBook
Galvanize Therapeutics General Information Description. Developer of energy-based medical device technology designed to improve biological processes. The company's platform utilizes …See details»
Galvanize Therapeutics - Funding, Financials, Valuation & Investors
Galvanize Therapeutics is funded by 4 investors. Gilmartin Capital LLC and Fidelity are the most recent investors. Galvanize Therapeutics has acquired 2 organizations. Their most recent …See details»
Galvanize - Overview, News & Similar companies | ZoomInfo.com
Nov 6, 2023 Galvanize Therapeutics Announces Promising Data on the Aliyaâ„¢ Pulsed Electric Field (PEF) System in Early-Stage Non-Small Cell Lung Cancer SAN DIEGO, Nov. 6, 2023 …See details»
Galvanize Therapeutics - Pulmonology On Air
About Galvanize TherapeuticsTM Galvanize Therapeutics aims to become the global leader in delivering medical technology innovations that drive biologic processes to treat a range of …See details»
Galvanize Therapeutics Announces Merger to Create the
SAN CARLOS, Calif., Sept. 15, 2022 /PRNewswire/ -- Galvanize Therapeutics, Inc., a commercial-stage biomedical platform company operating at the convergence of engineering, …See details»
With $100M, Galvanize Absorbs Two Biotechs to Advance
Sep 15, 2022 Gala Therapeutics and Galaxy Medical will be folded into Galvanize Therapeutics to continue to develop their electric pulse therapies for the non-thermal treatment of bronchitis, …See details»
About Galvanize Therapeutics – Galvanize
Steve is vice president of Global Market Development for the airway/COPD division of Galvanize Therapeutics. In this role, he leads commercial development activities for RheOx globally. …See details»
Galvanize Therapeutics Begins U.S. Clinical Study Using Aliya™ …
Sep 20, 2023 About Galvanize Therapeutics Galvanize Therapeutics aims to become the global leader in delivering medical technology innovations that drive biologic processes to treat a …See details»
Galvanize Therapeutics Announces Merger to Create the Premier …
SAN CARLOS, Calif., Sept. 15, 2022 /PRNewswire/ — Galvanize Therapeutics, Inc., a commercial-stage biomedical platform company operating at the convergence of engineering, …See details»
Galvanize Therapeutics Merges 3 Companies, Nabs $100M
Sep 15, 2022 Biomedical platform Galvanize Therapeutics announced on Thursday it raised $100 million in Series B financing led by Fidelity Management and Research Company, with …See details»
Three-way merger nets $100M in VC cash to Galvanize pulsed …
Sep 16, 2022 The platform will be adapted to help power Gala Therapeutics’ RheOx system, a CE-marked device for blunting the mucus-producing cells lining the airways of patients with …See details»
Galvanize Therapeutics Announces Promising Data on the Aliya™ …
SAN DIEGO, Nov. 6, 2023 /PRNewswire/ -- Galvanize Therapeutics, Inc., a leader in developing pulsed electric field therapies, unveiled compelling data from the INCITE-ES clinical study at …See details»
Galvanize Therapeutics Announces Merger to Create the Premier …
Sep 15, 2022 Merger unites three companies created by life sciences venture capital firm ATP—Gala Therapeutics, Galaxy Medical, and Galvanize Therapeutics—to create a single …See details»
Galvanize Receives FDA Clearance for the INUMI Flex Endoscopic …
May 28, 2024 Galvanize today announced that it received U.S. Food and Drug Administration 510(k) regulatory clearance for the INUMI Flex endoscopic needle for use with the Aliya® PEF …See details»
Apple Tree Partners | Galvanize Therapeutics Announces...
Sep 15, 2022 SAN CARLOS, Calif. – September 15, 2022 – Galvanize Therapeutics, Inc., a commercial-stage biomedical platform company operating at the convergence of engineering, …See details»
Galvanize raises $100M for pulsed electric field therapy platform
Sep 16, 2022 Galvanize Therapeutics Inc. scooped up $100 million in a series B funding round aimed at advancing its pulsed electric field (PEF) energy platform. Completion of the financing …See details»